Retinoic acid as antileukemic therapy in a patient with acute promyelocytic leukemia and Aspergillus pneumonia.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Blood

• Publication date

  1986-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V67.2.559.BLOODJOURNAL672559PMID 3455829
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Loss of suppression of normal bone marrow colony formation by leukemic cell lines after differentiation is induced by chemical agents.

  1985cited by this paper
• Probable in vivo induction of differentiation by retinoic acid of promyelocytes in acute promyelocytic leukaemia

  1984cited by this paper
• Phase I clinical trial of 13-cis-retinoic acid in myelodysplastic syndromes.

  1983cited by this paper
• Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications.

  1983cited by this paper
• Retinoic acid. Inhibition of the clonal growth of human myeloid leukemia cells.

  1982cited by this paper
• Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid.

  1981cited by this paper
• Terminal Differentiation of Human Promyelocytic Leukemic Cells in Primary Culture in Response to Retinoic Acid

  1981cited by this paper
• Normal levels of antithrombin III in acute leukemia complicated by coagulopathy.

  1980cited by this paper
• Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response.

  1977cited by this paper
• Successful control of systemic aspergillus niger infections in two patients with acute leukemia

  1975cited by this paper
• Aspergillosis complicating neoplastic disease.

  1973cited by this paper
• Relationship between Blast‐Cell Morphology and Occurrence of a Syndrome of Disseminated Intravascular Coagulation

  1973cited by this paper

• Spatiotemporal Expression of IRS-1 During Brain Development and its Role in Neural Stem Cell Differentiation

  2025cites this paper
• History of Developing Acute Promyelocytic Leukemia Treatment and Role of Promyelocytic Leukemia Bodies

  2024cites this paper
• Chemotherapy-free treatment for acute promyelocytic leukemia: the pediatric view of a revolutionary tale

  2023cites this paper
• The Promise of Retinoids in the Treatment of Cancer: Neither Burnt Out Nor Fading Away

  2023cites this paper
• Realgar (As4S4), a traditional Chinese medicine, induces acute promyelocytic leukemia cell death via the Bcl-2/Bax/Cyt-C/AIF signaling pathway in vitro

  2022cites this paper
• Drug treatment options for acute promyelocytic leukemia

  2021cites this paper
• Acute promyelocytic leukemia current treatment algorithms

  2021cites this paper
• MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSF

  2021cites this paper
• History of Acute Promyelocytic Leukemia

  2021cites this paper
• Case report: An unusual presentation of acute promyelocytic leukemia in a middle aged female mimicking dengue infection

  2020cites this paper
• Acute Promyelocytic Leukemia: A History over 60 Years—From the Most Malignant to the most Curable Form of Acute Leukemia

  2019cites this paper
• Cure of APL Without Chemotherapy

  2018cites this paper
• c-MYC and reactive oxygen species play roles in tetrandrine-induced leukemia differentiation

  2018cites this paper
• Self-Assembly Of Retinoid Nanoparticles For Melanoma Therapy

  2017cites this paper
• Top five medical innovations in China mainland since Xinhai revolution [1911]: results of AME survey-002.

  2015cites this paper
• Synergistic targeted therapy for acute promyelocytic leukaemia: a model of translational research in human cancer

  2015cites this paper
• Novel treatment of acute promyelocytic leukemia: As₂O₃, retinoic acid and retinoid pharmacology.

  2014cites this paper
• Early death in acute promyelocytic leukemia (APL) in French centers: a multicenter study in 399 patients

  2014cites this paper
• Progress in the treatment of acute promyelocytic leukemia: optimization and obstruction

  2014cites this paper
• A drug from poison: how the therapeutic effect of arsenic trioxide on acute promyelocytic leukemia was discovered

  2013cites this paper
• promyelocytic leukemia. I. Clinical results (see comments) All-trans retinoic acid as a differentiation therapy for acute

  2011cites this paper
• Differentiation therapy of leukemia: 3 decades of development.

  2009cites this paper
• Acute promyelocytic leukemia: from highly fatal to highly curable.

  2008influential citation
• Retinoic acid-induced CD38 antigen promotes leukemia cells attachment and interferon-gamma/interleukin-1beta-dependent apoptosis of endothelial cells: implications in the etiology of retinoic acid syndrome.

  2007cites this paper
• Perspectivesin CancerResearch Induction of Transformed Cells to Terminal Differentiation and the Modulation of Gene Expression1

  2006cites this paper
• A phase 1 and pharmacokinetic study using the aromatic retinoic acid analogue dichloroetretinate (Ro 12-7554)

  2004cites this paper
• Induction of Transforming Growth Factor-PI ( TGF-P , ) Receptor Expression and TGF-P , Protein Production in Retinoic Acid-Treated HL-60 Cells : Possible TGF-P ,-Mediated Autocrine Inhibition

  2003cites this paper
• Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001.

  2003cites this paper
• HL-60 cells : possible TGF-beta 1-mediated autocrine inhibition expression and TGF-beta 1 protein production in retinoic acid-treated Induction of transforming growth factor-beta 1 ( TGF-beta 1 ) , receptor

  2003cites this paper
• Transcription Factors that Regulate Growth and Differentiation of Myeloid Cells

  2001cites this paper
• Commentary on and reprint of Huang M-E, Ye Y-C, Chen S-R, Chai J-R, Lu J-X, Zhoa L, Gu L-J, Wang Z-Y, Use of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia, in Blood (1988) 72:567–572

  2000cites this paper
• Bibliography Articles Cited in Commentaries

  2000cites this paper
• Acute progranulocytic leukaemia: A model for molecular medicine

  1999cites this paper
• All‐trans‐retinoic acid up‐regulates CD38 but not c‐Kit antigens on human marrow CD34+ cells without recruitment into cell cycle

  1998cites this paper
• Induction of differentiation in human promyelocytic leukemia cell line HL60 by a new type of polyenes, falconensone A and its derivatives.

  1998cites this paper
• Tunicamycin in combination with retinoic acid synergistically inhibits cell growth while decreasing palmitoylation and enhancing retinoylation of proteins in the human breast cancer cell line MCF-7.

  1997cites this paper
• Differentiation therapy in myelodysplastic syndromes.

  1996cites this paper
• Blood Cell Biochemistry

  1996cites this paper
• Hematopoietic growth factors in leukemia.

  1996cites this paper
• Section Review: Oncologic, Endocrine & Metabolic: New advances in the treatment of acute promyelocytic leukaemia

  1996cites this paper
• O USO DO ÁCIDO ALL-TRANS RETINÓICO COMO AGENTE INDUTOR DE REMISSÃO EM PACIENTES COM DIAGNÓSTICO DE LEUCEMIA

  1996cites this paper
• Responses of Leukemia Cells to Hematopoietic Growth Factors

  1996cites this paper
• Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia

  1996cites this paper
• Acute promyelocytic leukemia: From clinic to molecular biology

  1995cites this paper
• Differentiation induction of human leukemia cells (HL60) by a combination of 1,25-dihydroxyvitamin D3 and retinoic acid (all trans or 9-cis).

  1995cites this paper
• Clinical and Molecular Advances in Acute Promyelocytic Leukaemia

  1995cites this paper
• Induction of retinoid resistance by all-trans retinoic acid in acute promyelocytic leukemia after remission.

  1995cites this paper
• Hemopoietic regulators and leukemia development: a personal retrospective.

  1994cites this paper
• Acute promyelocytic leukemia: from genetics to treatment.

  1994cites this paper
• [Complete remission in acute promyelocytic leukemia. The advantages of all-trans-retinoic acid compared to conventional chemotherapy].

  1994cites this paper
• Myeloid differentiation mediated through retinoic acid receptor/retinoic X receptor (RXR) not RXR/RXR pathway.

  1994cites this paper
• Induction of differentiation and covalent binding to proteins by the synthetic retinoids Ch55 and Am80.

  1994cites this paper
• Retinoids and differentiation treatment: a strategy for treatment in cancer.

  1994cites this paper
• Retinoylation of vimentin in the human myeloid leukemia cell line HL60.

  1994cites this paper
• Cytotoxicity, differentiating activity and metabolism of tiazofurin in human neuroblastoma cells

  1993cites this paper
• Hematopoietic growth factors and their receptors in acute leukemia.

  1993cites this paper
• Repeated complete remission in a patient with acute promyelocytic leukemia after treatment with 13-cis-retinoic acid first and with all-trans-retinoic acid in relapse

  1993cites this paper
• Treatment of acute promyelocytic leukemia with all-trans retinoic acid. A five-year experience.

  1993cites this paper
• Acute promyelocytic leukemia.

  1993cites this paper
• 9-cis-retinoic acid: effects on normal and leukemic hematopoiesis in vitro.

  1993cites this paper
• Transforming growth factor-beta potentiates vitamin D3-induced terminal monocytic differentiation of human leukemic cell lines.

  1993cites this paper
• 9-cis-retinoic acid : effects on normal and leukemic hematopoiesis in vitro

  1993cites this paper
• All-trans retinoic acid in the treatment of acute promyelocytic leukaemia.

  1992cites this paper
• Retinoids--"differentiation agents" for cancer treatment and prevention.

  1992cites this paper
• Trans-retinoic acid and related differentiation agents.

  1992cites this paper
• Haemopoietic growth factors in acute myeloblastic and lymphoblastic leukaemia.

  1992cites this paper
• Retinoids in Cancer Treatment

  1992cites this paper
• Retinoids in cancer therapy.

  1992cites this paper
• Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer.

  1992cites this paper
• Retinyl acetate and all-trans-retinoic acid enhance erythroid colony formation in vitro by circulating human progenitors in an improved serum-free medium.

  1992cites this paper
• Differentiation inducers and their potential use in the treatment of acute myelogenous leukaemia

  1992cites this paper
• All-trans retinoic acidにより寛解導入に成功した急性前骨髄性白血病小児再発例

  1992cites this paper
• Differentiation therapy.

  1992cites this paper
• Induction of transforming growth factor-beta 1 (TGF-beta 1), receptor expression and TGF-beta 1 protein production in retinoic acid-treated HL-60 cells: possible TGF-beta 1-mediated autocrine inhibition.

  1991cites this paper
• [Biological parameters of the efficiency of retinoic acid in acute leukemia].

  1991cites this paper
• OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside.

  1991cites this paper
• Retinoylation of proteins in leukemia, embryonal carcinoma, and normal kidney cell lines: differences associated with differential responses to retinoic acid.

  1991cites this paper
• Phase II Study of 13‐cis-Retinoic Acid in Pediatric Patients with Acute Nonlymphocytic Leukemia—A Pediatric Oncology Group Study

  1991cites this paper
• Retinoylation of the cAMP-binding regulatory subunits of type I and type II cAMP-dependent protein kinases in HL60 cells.

  1991cites this paper
• Retinoic acid inhibits sodium butyrate‐induced monocytic differentiation of HL60 cells while synergistically inducing granulocytoid differentiation

  1991cites this paper
• Vitamins and Cancer

  1991cites this paper
• Retinoic acid in acute promyelocytic leukemia: the promise and the paradox.

  1991cites this paper
• Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).

  1991cites this paper
• Low-dose chemotherapy and differentiating agents.

  1991cites this paper
• 3 – Interactions between Regulators and Chemotherapy Affecting the Blast Cells of Acute Myeloblastic Leukemia

  1991cites this paper
• A biological hypothesis for the FAB classification of acute myeloid leukaemias.

  1991cites this paper
• Retinoic acid in mono- or combined differentiation therapy of myelodysplasia and acute promyelocytic leukemia.

  1991cites this paper
• Practical aspects and diagnostic significance of in vitro manipulation of progenitors in human acute myeloid and lymphoid leukaemia.

  1991cites this paper
• All-Trans Retinoic Acid a s a Differentiation Therapy for Acute Promyelocytic Leukemia

  1990cites this paper
• Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.

  1990cites this paper
• All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship.

  1990cites this paper
• Pathobiology of myelodysplastic syndromes.

  1990cites this paper
• The retinoic acid receptor alpha gene is rearranged in retinoic acid-sensitive promyelocytic leukemias.

  1990cites this paper
• Effect of retinoids and 1,25(OH)2 vitamin D3 bound to their plasma transport proteins on growth and differentiation of HL-60 cells.

  1990cites this paper
• The influence of growth regulation on treatment strategy for acute myeloblastic leukaemia.

  1990cites this paper
• All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results.

  1990cites this paper
• Retinoylation of HL-60 proteins. Comparison to labeling by palmitic and myristic acids.

  1990cites this paper
• The unique aspects of acute promyelocytic leukemia.

  1990cites this paper
• Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.

  1990cites this paper
• Expression of a retinoic acid receptor gene in myeloid leukemia cells.

  1989cites this paper